Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1247386

	registered interest
	date	30/10/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Coronavirus: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether people who live in the same home as people who are clinically extremely vulnerable will receive a vaccine for covid-19 before the rest of the general public.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	109297
	answer	answer is ministerial correction date of answer 18/11/2020 answer text <p>Whilst there is a desire for the whole United Kingdom population to be vaccinated, there may need to be an element of prioritisation based on vaccine supply, availability and evidence as data emerges from clinical trials on safety and efficacy in different cohorts of the population.</p><p>The Joint Committee on Vaccination and Immunisation (JCVI) are the independent experts who provide advice to Government on which vaccine(s) the UK should use and which groups within the population to prioritise. The JCVI and the JCVI sub-committee are currently reviewing evidence on clinical risk factors associated with serious disease and mortality from COVID-19. Following a review of the evidence, the Committee will develop advice on risk groups for any future COVID-19 vaccination programme.</p><p>The latest JCVI recommendations on the priority groups for a COVID-19 vaccine is available at the following link:</p><p><a href="https://www.gov.uk/government/publications/priority-groups-for-coronavirus-covid-19-vaccination-advice-from-the-jcvi-25-september-2020" target="_blank">https://www.gov.uk/government/publications/priority-groups-for-coronavirus-covid-19-vaccination-advice-from-the-jcvi-25-september-2020</a></p><p>The minutes of JCVI committee meetings and statements on COVID-19 vaccination are available at the following link:</p><p><a href="https://www.gov.uk/government/groups/joint-committee-on-vaccination-and-immunisation" target="_blank">https://www.gov.uk/government/groups/joint-committee-on-vaccination-and-immunisation</a></p><p><strong> </strong></p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 18/11/2020 13:04:24 answering member 4380 label Biography information for Jo Churchill
	tabling member	3960 label Biography information for Henry Smith

1289683

	registered interest
	date	24/02/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cutaneous T-cell Lymphoma: Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the UK Rare Disease Framework, what steps he plans to take to engage with the rare blood cancer community to improve care coordination for people living with mycosis fungoides and Sézary syndrome, two subtypes of Cutaneous T-Cell Lymphoma, a rare blood cancer.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	158006
	answer	answer is ministerial correction date of answer 17/03/2021 answer text <p>We will continue to engage with a range of stakeholders, including the rare blood cancer community, before publishing action plans that outline how the priorities and underlying themes in the Framework will be addressed.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 17/03/2021 15:18:14 answering member 4380 label Biography information for Jo Churchill
	tabling member	3960 label Biography information for Henry Smith

1180311

	registered interest
	date	25/02/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Pancreatic Cancer: Surrey and Sussex
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what comparative assessment he has made of the level of surgery rates for people with pancreatic cancer in Surrey and Sussex and those rates in other areas of England; and what steps his Department plans to take to improve surgery rates in Surrey and Sussex.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	20451
	answer	answer is ministerial correction date of answer 04/03/2020 answer text <p>This information is not available as requested, and so no assessment has been made.</p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 04/03/2020 16:02:19 answering member 4380 label Biography information for Jo Churchill
	tabling member	3960 label Biography information for Henry Smith

1193071

	registered interest
	date	05/05/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Blood Cancer: Coronavirus
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many (a) men (b) women with blood cancer in each age group have (i) contracted covid-19 (ii) received intensive care support and (iii) died with covid-19.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	43625
	answer	answer is ministerial correction date of answer 29/05/2020 answer text <p>This data is not currently held.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 29/05/2020 15:07:52 answering member 4380 label Biography information for Jo Churchill
	tabling member	3960 label Biography information for Henry Smith

1293343

	registered interest
	date	01/03/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Coronavirus: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether data is being collected on covid-19 infections and admissions among clinically extremely vulnerable people who have been vaccinated.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	160624
	answer	answer is ministerial correction date of answer 09/03/2021 answer text <p>This data is not being collected in the format requested. Admissions and positive test data does not record those who are clinically extremely vulnerable or whether they have been vaccinated.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 09/03/2021 10:58:28 answering member 4380 label Biography information for Jo Churchill
	tabling member	3960 label Biography information for Henry Smith

1193067

	registered interest
	date	05/05/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Coronavirus: Disease Control
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many of the people who have been advised by the Government to shield at home for 12 weeks in response to the covid-19 outbreak (a) are undergoing active chemotherapy (b) have lung cancer who are undergoing radical radiotherapy; (c) have a cancer of the blood or bone marrow such as leukaemia, lymphoma or myeloma who are at any stage of treatment (d) are having immunotherapy or other continuing antibody treatments for cancer; (e) are having other targeted cancer treatments which can affect the immune system, such as protein kinase inhibitors or PARP inhibitors; (f) have had bone marrow or stem cell transplants in the last six months, or who are still taking immunosuppression drugs; (g) have severe respiratory conditions including all cystic fibrosis, severe asthma and severe chronic obstructive pulmonary; (h) have severe combined immunodeficiency and homozygous sickle cell or other rare diseases and inborn errors of metabolism that significantly increase the risk of infections; (i) are on immunosuppression therapies sufficient to significantly increase risk of infection and (j) are pregnant with significant heart disease, congenital or acquired.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	43621
	answer	answer is ministerial correction date of answer 29/05/2020 answer text <p>This data is currently unavailable.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 29/05/2020 15:30:36 answering member 4380 label Biography information for Jo Churchill
	tabling member	3960 label Biography information for Henry Smith

1471098

	registered interest
	date	16/06/2022
	answering body	Department for Environment, Food and Rural Affairs
	answering dept id	13
	answering dept short name	Environment, Food and Rural Affairs
	answering dept sort name	Environment, Food and Rural Affairs
	hansard heading	Package Holidays: Animal Welfare
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Environment, Food and Rural Affairs, if he will introduce a ban on the domestic (a) advertising and (b) sale of (i) elephant rides and (ii) other wild animal experiences overseas.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	19607
	answer	answer is ministerial correction date of answer 21/06/2022 answer text <p>This Government takes the welfare of all animals seriously and the Government has been made aware that animals including Asian elephants, that are part of tourist attractions, can be subjected to cruel and brutal training practices to ensure their compliance.</p><p> </p><p>As set out in our Action Plan for Animal Welfare, we are committed to promoting high animal welfare standards, both at home and abroad. We have engaged with the travel industry and other stakeholder organisations, and we support measures which ensure that money from tourists from this country is not channelled towards animal experiences abroad that involve the unacceptable treatment of animals.</p><p>The Government is committed to exploring available options to deliver the action plan, including to limit the advertising and offering for sale of these experiences.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill grouped question UIN 17932 17967 question first answered 21/06/2022 17:06:56 answering member 4380 label Biography information for Jo Churchill
	tabling member	3960 label Biography information for Henry Smith

1243942

	registered interest
	date	15/10/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Bowel Cancer
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the adequacy of the care and treatment provided to people with metastatic colorectal cancer in England in light of survival rates being lower than comparable European countries.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	104094
	answer	answer is ministerial correction date of answer 27/11/2020 answer text <p>There is a wide range of treatment options available to manage metastatic colorectal cancer and these are set out within pathway guidance published by the National Institute for Health and Care Excellence.</p><p>While treatment decisions are based on individual clinical circumstances, systemic anti-cancer treatment is the mainstay of care. There are a number of treatments available depending on where the colorectal cancer has spread. For example, where cancer is in the liver, patients may be able to access interventional procedures including laparoscopic resection and ablative treatments as well as radiotherapy (Selective Internal Radiation Therapy and Stereotactic Ablative Radiotherapy).</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 27/11/2020 12:10:22 answering member 4380 label Biography information for Jo Churchill
	tabling member	3960 label Biography information for Henry Smith

1190702

	registered interest
	date	27/04/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Blood Cancer: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many people with blood cancer have had (a) CAR-T cell therapy and (b) a stem cell transplant in each of the last six months for which data is available.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	40579
	answer	answer is ministerial correction date of answer 04/05/2020 answer text <p>The table shows the number of patients who have been infused with manufactured chimeric antigen receptor T (CAR T) cells. NHS England/Improvement report that the number of patients who have undergone apheresis (separating a particular blood constituent but returning the remainder to circulation) with an intention to treat will be significantly higher.</p><table><tbody><tr><td rowspan="2"><p>Indication</p></td><td colspan="3"><p>2019</p></td><td colspan="3"><p>2020</p></td><td rowspan="2"><p>Grand Total</p></td></tr><tr><td><p>10</p></td><td><p>11</p></td><td><p>12</p></td><td><p>1</p></td><td><p>2</p></td><td><p>3</p></td></tr><tr><td><p>Acute Lymphoblastic Leukaemia (ALL)</p></td><td><p>Less than 5</p></td><td><p>Less than 5</p></td><td><p>Less than 5</p></td><td><p>Less than 5</p></td><td><p>Less than 5</p></td><td><p>Less than 5</p></td><td><p>6</p></td></tr><tr><td><p>Diffuse Lage B-Cell Lymphoma (DLBCL)</p></td><td><p>15</p></td><td><p>7</p></td><td><p>15</p></td><td><p>12</p></td><td><p>13</p></td><td><p>13</p></td><td><p>75</p></td></tr></tbody></table><p> </p><p> </p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 04/05/2020 11:57:27 answering member 4380 label Biography information for Jo Churchill
	tabling member	3960 label Biography information for Henry Smith

1199796

	registered interest
	date	02/06/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Blood Cancer: Coronavirus
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many people with blood cancer have been removed from the shielding list by (a) clinicians and (b) GPs in England.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	53399
	answer	answer is ministerial correction date of answer 12/06/2020 answer text <p>The shielded patient list is dynamic – general practitioners and specialists continue to make clinical judgements based the shielding criteria, that may result in those who had initially been advised to shield from COVID-19 no longer being advised to do so. Doctors have also been provided with guidance to support these decisions, which should be made following discussion with the patient and taking into account their individual clinical circumstances.</p><p>Information on the number of patients removed from the shielded patient list is not held centrally.</p><p> </p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill grouped question UIN 53400 question first answered 12/06/2020 12:24:33 answering member 4380 label Biography information for Jo Churchill
	tabling member	3960 label Biography information for Henry Smith